Search Results - Paul Kirschmeier

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Thematic review series: Lipid Posttranslational Modifications. Farnesyl transferase inhibitors

    Thematic review series: Lipid Posttranslational Modifications. Farnesyl transferase inhibitors by Andrea D. Basso, Paul Kirschmeier, W. Robert Bishop

    Published 2006-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor Immunity

    Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor Immunity by Juan J. Miret, Paul Kirschmeier, Shohei Koyama, Mingrui Zhu, Yvonne Y. Li, Yujiro Naito, Min Wu, Venkat S. Malladi, Wei Huang, William Walker, Sangeetha Palakurthi, Glenn Dranoff, Peter S. Hammerman, Chad V. Pecot, Kwok-Kin Wong, Esra A. Akbay

    Published 2019-02-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterations

    Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterations by Atsuko Ogino, Jihyun Choi, Mika Lin, Margaret K. Wilkens, Antonio Calles, Man Xu, Anika E. Adeni, Emily S. Chambers, Marzia Capelletti, Mohit Butaney, Nathanael S. Gray, Prafulla C. Gokhale, Sangeetha Palakurthi, Paul Kirschmeier, Geoffrey R. Oxnard, Lynette M. Sholl, Pasi A. Jänne

    Published 2021-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: